Creative Medical Technology Holdings, Inc. Derivative Liability, Current
Creative Medical Technology Holdings, Inc. (CELZ) had Derivative Liability, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2022-03-30
- 2021-12-31: Derivative Liability, Current $0.00.
- 2021-09-30: Derivative Liability, Current $0.00.
- 2021-06-30: Derivative Liability, Current $248.10K.
- 2021-03-31: Derivative Liability, Current $2.28M.
| Period end | Derivative Liability, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $248.10K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.28M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $38.74M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.57M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.81M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.84M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.85M 10-K · filed 2021-03-17 |
| 2019-09-30 | $2.54M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.38M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.53M 10-Q · filed 2019-05-20 |
| 2018-12-31 | $3.23M 10-K · filed 2020-04-06 |
| 2018-09-30 | $6.82M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $9.93M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.05M 10-Q · filed 2018-08-03 |
| 2017-12-31 | $1.31M 10-K · filed 2019-04-01 |
| 2017-09-30 | $401.46K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $681.06K 10-Q · filed 2017-08-14 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |